Published in Australas Ann Med on November 01, 1965
Ristocetin--a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh (1971) 2.76
An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues. Biochem Biophys Res Commun (1967) 2.55
Stimulation of insulin secretion by theophylline. Nature (1967) 1.89
Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet (1980) 1.65
Defective DNA synthesis in human megaloblastic bone marrow: effects of hydroxy-B 12 5'-deoxyadenosyl-B 12 and methyl-B 12 . Blood (1973) 1.60
Pathogenesis of diabetic microangiopathy: the roles of endothelial cell and basement membrane abnormalities. Diabet Med (1992) 1.44
Sharing the care of diabetic patients between hospital and general practitioners: does it work? Diabet Med (1993) 1.40
Diabetes to the year 2000 and beyond. National Action Plan. Med J Aust (1993) 1.38
A new assay for adenosine 3',5'-cyclic monophosphate in tissue. Biochemistry (1967) 1.35
Development of the diabetes knowledge (DKN) scales: forms DKNA, DKNB, and DKNC. Diabetes Care (1984) 1.30
Testicular function in potential sperm donors: normal ranges and the effects of smoking and varicocele. Int J Androl (1984) 1.29
Ristocetin: a means of differentiating von Willebrand's disease into two groups. Blood (1973) 1.28
Somatogenic receptors of rat liver: regulation by insulin. Endocrinology (1980) 1.23
Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem (1982) 1.22
Adrenal function in patients with active tuberculosis. Thorax (1989) 1.21
Retracted Study of the factors that cause specific transformation in cultures of lymphocytes from patients with quinine- and quinidine-induced immune thrombocytopenia. J Clin Invest (1980) 1.19
Abnormalities of insulin secretion in dystrophia myotonica. Brain (1970) 1.18
Changes in hepatic glutathione metabolism in diabetes. Diabetes (1991) 1.16
Retracted Quinine- and quinidine-dependent antiplatelet antibodies. Requirement of factor VIII-related antigen for platelet damage and for in vitro transformation of lymphocytes from patients with drug-induced thrombocytopenia. J Clin Invest (1981) 1.14
Secondary amenorrhea with inappropriate lactation. Observations on etiology, estrogen-gonadotropin interrelationships, the behavior of human growth hormone, and the response to treatment. Am J Obstet Gynecol (1970) 1.13
New forms of insulin and their use in the treatment of diabetes. Diabetes (1977) 1.13
Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabet Med (1988) 1.12
Antigenicity of "monocomponent" pork insulin in diabetic subjects. Diabetes (1975) 1.11
Cloning of TC-1 (C8orf4), a novel gene found to be overexpressed in thyroid cancer. Genomics (2000) 1.10
Standard nomenclature for factor VIII and von Willebrand factor: a recommendation by the International Committee on Thrombosis and Haemostasis. Thromb Haemost (1985) 1.10
High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+. Cell Calcium (1990) 1.08
Hypoglycemic action of fenfluramine in diabetes mellitus. Diabetes (1973) 1.07
Young's syndrome. Obstructive azoospermia and chronic sinopulmonary infections. N Engl J Med (1984) 1.07
Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer. Clin Endocrinol (Oxf) (1983) 1.04
Comparison of laboratory tests used for identification of the lupus anticoagulant. Am J Hematol (1989) 1.03
Perifusion and culture of human fetal pancreas. Diabetes (1980) 1.03
A method for estimation of Krebs cycle and related intermediates in animal tissues by gas chromatography. Anal Biochem (1968) 1.02
Anti-smoking programme for diabetic patients: the agony and the ecstasy. Diabet Med (1989) 1.02
Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabet Med (1996) 1.02
The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes (1982) 1.00
von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. Proc Natl Acad Sci U S A (1992) 0.99
A high prevalence of obesity in a diabetic population: results of a survey of food patterns in 252 patients in a 2 year period. Diabetes Res Clin Pract (1985) 0.99
The measurement of glycosylated hemoglobin in man and animals by aminophenylboronic acid affinity chromatography. Diabetes (1982) 0.99
Diabetes in the Melanesian and Indian peoples of Fiji: a study of risk factors. Diabetes Res Clin Pract (1987) 0.99
The prevention and reversibility of tissue non-enzymatic glycosylation in diabetes. Diabet Med (1986) 0.98
Splenic macrophages in thrombocytopenia. Blood (1969) 0.97
C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus. Metabolism (1978) 0.96
The splenic platelet pool. Blood (1966) 0.95
Purification of the insulin receptor from human placental membranes. Biochim Biophys Acta (1979) 0.95
Abnormalities of granulation tissue and collagen formation in experimental diabetes, uraemia and malnutrition. Diabet Med (1986) 0.94
Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun (1978) 0.94
The thermal stability of collagen in diabetic rats: correlation with severity of diabetes and non-enzymatic glycosylation. Diabetologia (1983) 0.94
Knowledge and attitude change as predictors of metabolic improvement in diabetes education. Soc Sci Med (1990) 0.93
The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance. Biochem J (1987) 0.93
Inhibition of insulin secretion by a phaeochromocytoma. Lancet (1966) 0.93
The effect of body weight and the fatty acid-oxidation inhibitor 2-tetradecylglycidic acid on pyruvate dehydrogenase complex activity in mouse heart. Biochem J (1984) 0.93
Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk. J Clin Endocrinol Metab (1984) 0.93
Measurement of emotional adjustment in diabetic patients: validity and reliability of ATT39. Diabetes Care (1986) 0.92
Glycosylation of plasma protein and its relation to glycosylated hemoglobin in diabetes. Diabetes (1980) 0.92
Factor VIII physiology and pathology in man. Prog Hematol (1979) 0.92
High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes (1994) 0.91
Histologic differentiation of human fetal pancreatic explants transplanted into nude mice. Diabetes (1984) 0.91
Non-enzymatic glycosylation of tissue protein in diabetes in the rat. Diabetologia (1983) 0.91
Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant. Br J Haematol (1990) 0.91
A single visit diabetes complication assessment service: a complement to diabetes management at the primary care level. Diabet Med (1993) 0.90
Relationship of raised platelet IgG in thrombocytopenia to total platelet protein content. Br J Haematol (1981) 0.90
Interaction between diabetic patients, their general practitioners and a hospital diabetic clinic. Med J Aust (1991) 0.89
Calcium-dependence of insulin receptor phosphorylation. Biochem J (1983) 0.89
Further studies of the interaction between ristocetin and fibrinogen. Haemostasis (1976) 0.89
Purification of human placental lactogen. Endocrinology (1966) 0.89
The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane. Br J Haematol (1984) 0.89
Maturation of the response of human fetal pancreatic explants to glucose. Diabetologia (1985) 0.88
An analysis of hypoplastic anaemia with special reference to the use of oxymetholone ("Adroyd") in its therapy. Australas Ann Med (1968) 0.88
Lupus anticoagulant in women with multiple spontaneous miscarriage. Am J Hematol (1987) 0.88
Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes (1989) 0.88
Colonic and oesophageal disturbance in a patient with multiple endocrine neoplasia, type 2b. Aust N Z J Med (1978) 0.87
Physiological and pharmacological aspects of the platelet. Annu Rev Pharmacol (1969) 0.86
Ovarian function after renal transplantation: comparison of cyclosporin A with azathioprine and prednisone combination regimens. Br J Obstet Gynaecol (1984) 0.86
Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy. Gut (1983) 0.86
The effects of fasting and refeeding on liver glycogen synthase and phosphorylase in obese and lean mice. Horm Metab Res (1992) 0.86
Proportion of active dephosphorylated pyruvate dehydrogenase complex in heart and isolated heart mitochondria is decreased in obese hyperinsulinaemic mice. Biochem J (1984) 0.86
Glucose and insulin secretory response patterns following diet and tolazamide therapy in diabetes. Br Med J (1970) 0.85
Testicular function after renal transplantation. Clin Endocrinol (Oxf) (1981) 0.85
Effects of experimental diabetes, uremia, and malnutrition on wound healing. Diabetes (1987) 0.85
Interaction of ascorbic acid and glucose on production of collagen and proteoglycan by fibroblasts. Diabetes (1991) 0.85
Rat growth hormone (GH) but not prolactin (PRL) induces both GH and PRL receptors in female rat liver. Endocrinology (1984) 0.84
Further studies on the factor VIII of a patient with a variant form of von Willebrand's disease. Thromb Res (1979) 0.84
The aggregation of human platelets by ascitic fluid: a possible mechanism for disseminated intravascular coagulation complicating LeVeen shunts. Am J Hematol (1981) 0.84
High glucose reduces generation of plasmin activity by mesangial cells. Microvasc Res (1997) 0.83
Orotic aciduria. Differing enzyme patterns. Am J Med (1969) 0.83
Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura: a report of five cases. Med J Aust (1979) 0.83
Variant von Willebrand's disease type B--revisited. Blood (1982) 0.83
Investigations of the lupus-like inhibitor by-passing activity of platelets. Thromb Haemost (1983) 0.83
Qualitative platelet defects with reduced life-span in acute leukaemia. Aust N Z J Med (1972) 0.83
Azoospermia after iodine-131 treatment for thyroid carcinoma. Br Med J (1980) 0.83
Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span. Thromb Res (1980) 0.83
The lipolytic action of human placental lactogen on isolated fat cells. Biochim Biophys Acta (1967) 0.82
Radioimmunoassay of human plasma apolipoproteins part 1. assay of apolipoprotein-B. Atherosclerosis (1975) 0.82
Iron overload in congenital erythrocyte pyruvate kinase deficiency. Med J Aust (1980) 0.82
Equilibrium binding studies of insulin antibodies in diabetic subjects. Clin Chem (1976) 0.82
Streptozotocin is not toxic to the human fetal B cell. Diabetologia (1989) 0.82
Association of increased immune complexes, platelet IgG and serum IgG in chronic active hepatitis. Clin Exp Immunol (1983) 0.81
Leg pain and platelet aggregates in thrombocythemic myeloproliferative disease. JAMA (1980) 0.81